These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice. Ng CJ; Bourquard N; Hama SY; Shih D; Grijalva VR; Navab M; Fogelman AM; Reddy ST Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1368-74. PubMed ID: 17446441 [TBL] [Abstract][Full Text] [Related]
23. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833 [TBL] [Abstract][Full Text] [Related]
24. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499 [TBL] [Abstract][Full Text] [Related]
25. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins. Aviram M Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155 [TBL] [Abstract][Full Text] [Related]
26. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. Draganov DI; Teiber JF; Speelman A; Osawa Y; Sunahara R; La Du BN J Lipid Res; 2005 Jun; 46(6):1239-47. PubMed ID: 15772423 [TBL] [Abstract][Full Text] [Related]
27. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641 [TBL] [Abstract][Full Text] [Related]
28. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action. Nguyen SD; Sok DE Free Radic Res; 2003 Dec; 37(12):1319-30. PubMed ID: 14753756 [TBL] [Abstract][Full Text] [Related]
30. Paraoxonases-1, -2 and -3: What are their functions? Furlong CE; Marsillach J; Jarvik GP; Costa LG Chem Biol Interact; 2016 Nov; 259(Pt B):51-62. PubMed ID: 27238723 [TBL] [Abstract][Full Text] [Related]
31. The paraoxonase gene family and atherosclerosis. Ng CJ; Shih DM; Hama SY; Villa N; Navab M; Reddy ST Free Radic Biol Med; 2005 Jan; 38(2):153-63. PubMed ID: 15607899 [TBL] [Abstract][Full Text] [Related]
32. Lack of protection against oxidative modification of LDL by avian HDL. Mackness B; Durrington PN; Mackness MI Biochem Biophys Res Commun; 1998 Jun; 247(2):443-6. PubMed ID: 9642147 [TBL] [Abstract][Full Text] [Related]
33. Inflammation, infection, cancer and all that…the role of paraoxonases. Devarajan A; Shih D; Reddy ST Adv Exp Med Biol; 2014; 824():33-41. PubMed ID: 25038992 [TBL] [Abstract][Full Text] [Related]
34. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice. She ZG; Zheng W; Wei YS; Chen HZ; Wang AB; Li HL; Liu G; Zhang R; Liu JJ; Stallcup WB; Zhou Z; Liu DP; Liang CC Circ Res; 2009 May; 104(10):1160-8. PubMed ID: 19359600 [TBL] [Abstract][Full Text] [Related]
35. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Aviram M; Rosenblat M Free Radic Biol Med; 2004 Nov; 37(9):1304-16. PubMed ID: 15454271 [TBL] [Abstract][Full Text] [Related]
36. The three-gene paraoxonase family: physiologic roles, actions and regulation. Précourt LP; Amre D; Denis MC; Lavoie JC; Delvin E; Seidman E; Levy E Atherosclerosis; 2011 Jan; 214(1):20-36. PubMed ID: 20934178 [TBL] [Abstract][Full Text] [Related]
37. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation. Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818 [TBL] [Abstract][Full Text] [Related]